These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15161564)

  • 1. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management.
    Cooperberg MR; Broering JM; Latini DM; Litwin MS; Wallace KL; Carroll PR
    Curr Urol Rep; 2004 Jun; 5(3):166-72. PubMed ID: 15161564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
    Cooperberg MR; Broering JM; Litwin MS; Lubeck DP; Mehta SS; Henning JM; Carroll PR;
    J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The example of CaPSURE: lessons learned from a national disease registry.
    Porten SP; Cooperberg MR; Konety BR; Carroll PR
    World J Urol; 2011 Jun; 29(3):265-71. PubMed ID: 21347810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
    Koppie TM; Grossfeld GD; Miller D; Yu J; Stier D; Broering JM; Lubeck D; Henning JM; Flanders SC; Carroll PR
    J Urol; 2000 Jul; 164(1):81-8. PubMed ID: 10840429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
    Cooperberg MR; Hinotsu S; Namiki M; Ito K; Broering J; Carroll PR; Akaza H
    J Clin Oncol; 2009 Sep; 27(26):4306-13. PubMed ID: 19667269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
    JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer 2004: insights from national disease registries.
    Cooperberg MR; Park S; Carroll PR
    Oncology (Williston Park); 2004 Sep; 18(10):1239-47; discussion 1248-50, 1256-8. PubMed ID: 15526829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.
    Lubeck DP; Litwin MS; Henning JM; Stier DM; Mazonson P; Fisk R; Carroll PR
    Urology; 1996 Nov; 48(5):773-7. PubMed ID: 8911524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
    Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK
    Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).
    Cooperberg MR; Lubeck DP; Mehta SS; Carroll PR;
    J Urol; 2003 Dec; 170(6 Pt 2):S21-5; discussion S26-7. PubMed ID: 14610406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base.
    Martin JM; Handorf EA; Kutikov A; Uzzo RG; Bekelman JE; Horwitz EM; Smaldone MC
    Cancer; 2014 Jul; 120(14):2114-21. PubMed ID: 24737481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urologists reduce overtreatment in prostate cancer.
    Das M
    Lancet Oncol; 2018 Aug; 19(8):e384. PubMed ID: 29937393
    [No Abstract]   [Full Text] [Related]  

  • 17. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.
    Jain AL; Sidana A; Maruf M; Sugano D; Calio B; Wood BJ; Pinto PA
    Urol Oncol; 2019 Mar; 37(3):182.e1-182.e8. PubMed ID: 30522903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician visits prior to treatment for clinically localized prostate cancer.
    Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
    Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.
    Glass AS; Cowan JE; Fuldeore MJ; Cooperberg MR; Carroll PR; Kenfield SA; Greene KL
    Urology; 2013 Jul; 82(1):60-5. PubMed ID: 23706257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.